These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 32032642)
21. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes. Patel PJ; Gajera BY; Dave RH Drug Dev Ind Pharm; 2018 Dec; 44(12):1942-1952. PubMed ID: 30027778 [TBL] [Abstract][Full Text] [Related]
22. Synthesis and in vitro release study of ibuprofen-loaded gelatin graft copolymer nanoparticles. Haroun AA; El-Halawany NR; Loira-Pastoriza C; Maincent P Drug Dev Ind Pharm; 2014 Jan; 40(1):61-5. PubMed ID: 23244199 [TBL] [Abstract][Full Text] [Related]
23. Determination of factors controlling the particle size and entrapment efficiency of noscapine in PEG/PLA nanoparticles using artificial neural networks. Shalaby KS; Soliman ME; Casettari L; Bonacucina G; Cespi M; Palmieri GF; Sammour OA; El Shamy AA Int J Nanomedicine; 2014; 9():4953-64. PubMed ID: 25364252 [TBL] [Abstract][Full Text] [Related]
24. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization. Abd-Elrahman AA; El Nabarawi MA; Hassan DH; Taha AA Drug Deliv; 2016 Nov; 23(9):3387-3398. PubMed ID: 27167529 [TBL] [Abstract][Full Text] [Related]
25. Artificial neural networks (ANNs) and partial least squares (PLS) regression in the quantitative analysis of cocrystal formulations by Raman and ATR-FTIR spectroscopy. Barmpalexis P; Karagianni A; Nikolakakis I; Kachrimanis K J Pharm Biomed Anal; 2018 Sep; 158():214-224. PubMed ID: 29886369 [TBL] [Abstract][Full Text] [Related]
26. Poloxamer 407 microspheres for orotransmucosal drug delivery. Part I: formulation, manufacturing and characterization. Albertini B; Passerini N; Di Sabatino M; Monti D; Burgalassi S; Chetoni P; Rodriguez L Int J Pharm; 2010 Oct; 399(1-2):71-9. PubMed ID: 20696227 [TBL] [Abstract][Full Text] [Related]
27. Preparation of amorphous cefuroxime axetil nanoparticles by controlled nanoprecipitation method without surfactants. Zhang JY; Shen ZG; Zhong J; Hu TT; Chen JF; Ma ZQ; Yun J Int J Pharm; 2006 Oct; 323(1-2):153-60. PubMed ID: 16828244 [TBL] [Abstract][Full Text] [Related]
29. Design and optimization of NSAID loaded nanoparticles. Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573 [TBL] [Abstract][Full Text] [Related]
30. Preparation of magnetic gelatin nanoparticles and investigating the possible use as chemotherapeutic agent. Yılmaz H; Sanlıer SH Artif Cells Nanomed Biotechnol; 2013 Apr; 41(2):69-77. PubMed ID: 23305120 [TBL] [Abstract][Full Text] [Related]
38. Mechanical properties of gelatin nanoparticles in dependency of crosslinking time and storage. Weiss AV; Fischer T; Iturri J; Benitez R; Toca-Herrera JL; Schneider M Colloids Surf B Biointerfaces; 2019 Mar; 175():713-720. PubMed ID: 30612047 [TBL] [Abstract][Full Text] [Related]
39. Diclofenac acid nanocrystals as an effective strategy to reduce in vivo skin inflammation by improving dermal drug bioavailability. Pireddu R; Caddeo C; Valenti D; Marongiu F; Scano A; Ennas G; Lai F; Fadda AM; Sinico C Colloids Surf B Biointerfaces; 2016 Jul; 143():64-70. PubMed ID: 26998867 [TBL] [Abstract][Full Text] [Related]
40. Electrospinning of PVA/chitosan nanocomposite nanofibers containing gelatin nanoparticles as a dual drug delivery system. Fathollahipour S; Abouei Mehrizi A; Ghaee A; Koosha M J Biomed Mater Res A; 2015 Dec; 103(12):3852-62. PubMed ID: 26112829 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]